Sickle Cell Disease

• 10/25/2024

  “Revolutionizing Disease Treatment: The $10 Billion Gene Editing Opportunity”

• 10/7/2024

  **Activist Investor Takes $1B Stake in Pfizer, Enlists Former Execs**

• 10/1/2024

  **Editas Medicine Presents at 8th Annual Genetic Medicines Conference (Transcript)**